Kristen Ambrose, SVP & Chief Accounting Officer: Vertex Pharmaceuticals VRTX Sell · Filed 02/19

Trade details

Type: Insider sale
Amount: $762,089.22
Shares · price: 1,557 sh · $489.46 a share
Held after: 8,388 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Kristen AmbroseSVP & Chief Accounting Officer
Trade date: 26/02/17
Filed: 26/02/19
Days to filing: 2 days

Sold 15.7% of holdings

Share of holding sold: 15.7%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/18~03/19

Kristen Ambrose's recent trades

Kristen AmbroseSVP & Chief Accounting Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$172.6K
357 sh
$172.6K
Filed 03/02
Traded 02/26
Kristen AmbroseSVP & Chief Accounting Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$108.5K
223 sh
$108.5K
Filed 02/26
Traded 02/25
Kristen AmbroseSVP & Chief Accounting Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$302.2K
638 sh
$302.2K
Filed 02/19
Traded 02/18
Kristen AmbroseSVP & Chief Accounting Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$633.6K
1,376 sh
$633.6K
Filed 02/12
Traded 02/11
Kristen AmbroseSVP & Chief Accounting Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$425.2K
884 sh
$425.2K
Filed 25/02/26
Traded 25/02/25

Kristen Ambrose, CAO — sold $762.1K of Vertex Pharmaceuticals VRTX · 15.7% of holdings · 10b5-1 plan | Whalegun